Edward Owens

CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.

Wuhan Zhongyuan Ruide Biological Products Co., Ltd. engages in the research and development, manufacture, and sale of biological products and blood products. The company was founded on on June 11, 2010 and is headquartered in Wuhan, China.

Part of CSL Ltd., CSL Behring Holdings GmbH is a German company that functions as an investment holding company. The company is based in Marburg, Germany. The CEOs are Val Gene Romberg, Berthold Suesser. The company was founded in 2014.

Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy.

Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ.

Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.

Seqirus UK Ltd. manufactures vaccines. Its brands offer include Dukoral, Gardasil, Jespect, Menveo, Panvax, Rabipur, Vaqta, Benpen, Palexia, Rapivab, Tramal, and Versatis. The company was founded on July 31, 2015 and is headquartered in Maidenhead, the United Kingdom.

Part of CSL Ltd., CSL Finance Plc provides finance services for group companies. The company is based in Haywards Heath, UK. The British company was founded in 2002. The CEO is Paul Roger Perreault.

Guangzhou Junxin Pharmaceutical Ltd. engages in the sale of Western medicines. Its business activities include medical device and blood product management, and import and export business. The company was founded on September 17, 2003 and is headquartered in Guangzhou, China.

Part of CSL Ltd., Seqirus Holdings UK Ltd. is an investment holding company. The company is based in Maidenhead, UK. Seqirus Holdings was founded in 2015.

Part of CSL Ltd., CSL Finance GmbH is a German company that provides investment services. The company is based in Marburg, Germany. The CEOs are Antje Michel, Dieter Engstfeld, John Andrew Goodman Levy. The company was founded in 2014.

Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.

CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium.